Members |
targetComponentId |
Thoracoabdominal aortic aneurysm, without mention of rupture |
Thoracoabdominal aortic aneurysm |
Thorny headed worm |
Phylum Acanthocephala (organism) |
tusind/µl |
x10^3/microliter |
Threatened abortion (antepartum) |
Threatened miscarriage |
truende abort, barn født |
Threatened miscarriage |
Threatened abortion, unspecified as to episode of care |
Threatened miscarriage |
Tre piger |
Number of female fetuses |
Three female babies |
Number of female fetuses |
360 graders translokation af macula |
Translocation of retina (procedure) |
Tre drengebørn |
Number of male fetuses |
Three male babies |
Number of male fetuses |
abort nr. 3 |
Past pregnancy history of multiple induced termination of pregnancy |
antiinfektiøst halspræparat |
Product manufactured as oromucosal dose form (product) |
halspræparat |
Product manufactured as oromucosal dose form (product) |
Thrombocytopenia NOS |
Thrombocytopenic disorder |
Thrombocytopenia NOS |
Thrombocytopenic disorder |
Thrombocytopenia: [congenital purpura] or [hereditary NEC] |
Hereditary thrombocytopenic disorder (disorder) |
Thrombolytic agent |
Thrombolytic agent (substance) |
trombofili som følge af erhvervet protein C-mangel |
Acquired protein C deficiency (disorder) |
trombofili som følge af erhvervet protein S-mangel |
Acquired protein S deficiency |
Thrombosis of renal vein |
Thrombosis of renal vein |
Thrombosis of vein NOS |
Venous thrombosis |
Thrombosis of vein NOS |
Venous thrombosis |
Thrombotic microangiopathy NOS |
Thrombotic microangiopathy |
trombe forårsaget af en anordning, et implantat OG/ELLER en graft |
Thrombosis (disorder) |
Thumb X-ray |
Plain X-ray of thumb (procedure) |
Røntgenundersøgelse af tommelfinger |
Plain X-ray of thumb (procedure) |
Thumb X-ray |
Plain X-ray of thumb (procedure) |
Thumb pulp flap |
Flap (substance) |
tymom iht. kategori |
Thymoma |
tymom |
Thymoma of uncertain behaviour |
Tymom, type A |
Thymoma, type A, malignant |
Tymom, type AB |
Thymoma, type AB, malignant (morphologic abnormality) |
Tymom, type B1 |
Thymoma, type B1, malignant |
Tymom, type B2 |
Thymoma, type B2, malignant (morphologic abnormality) |
Tymom, type B3 |
Thymoma, type B3, malignant (morphologic abnormality) |
Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial |
Product containing only thymalfasin (medicinal product) |
thymosin alfa 1 1,6 mg pulver til injektionsvæske, opløsning, hætteglas + diluent |
Product containing only thymalfasin (medicinal product) |
Thymoxamine 0.5% conventional release eye drops |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
thymoxamin 0,5 % øjendråber uden konserveringsmiddel |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
fund vedr. thyroidea udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
Thyroid disease monitoring NOS |
Thyroid disease monitoring |
Thyroid disease monitoring NOS |
Thyroid disease monitoring |
Thyroid eye disease with exophthalmos |
Exophthalmos due to thyroid eye disease (disorder) |
Thyroid eye disease with strabismus |
Exophthalmos due to thyroid eye disease (disorder) |
Thyroid gland excision |
Thyroidectomy |
Thyroid incision NOS |
Incision of thyroid |
Thyroid incision NOS |
Incision of thyroid |
Thyroid related antibody |
Thyroid antibody |
Thyroiditis NOS |
Thyroiditis |
Thyroiditis NOS |
Thyroiditis |
Thyrotoxicosis NOS |
Thyrotoxicosis |
Thyrotoxicosis NOS |
Thyrotoxicosis |
thyrotropin alfa 0,9 mg pulver til injektionsvæske, opløsning, hætteglas |
Thyrotrophin only product |
thyrotropin alfa 1,1 mg/hætteglas pulver |
Thyrotrophin only product |
Thyroxine sodium 100micrograms tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
Thyroxine sodium 25micrograms tablet |
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) |
Thyroxine sodium 50micrograms tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
Røntgenundersøgelse af tibia |
Plain X-ray of tibia |
Tic disorder unspecified |
Tic (finding) |
Tics-sygdom, uspecificeret |
Tic (finding) |
ticarcillin 3 g + clavulansyre 100 mg pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
ticarcillindinatrium 1 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
ticarcillindinatrium 20 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
ticarcillindinatrium 3 g pulver til injektionsvæske, opløsning, hætteglas |
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Tiludronate disodium |
Product containing tiludronic acid (medicinal product) |
Time since symptom started NOS |
Symptom findings in relation to start time |
Time since symptom started NOS |
Symptom findings in relation to start time |
Time symptom lasts NOS |
Symptom findings in relation to time lasts |
Time symptom lasts NOS |
Time symptom lasts |
Time zone syndrome |
Jet lag (finding) |
tidsregistreret balancetest uden ydre støtte |
Timed unsupported steady stand time |
timololmaleat 0,25% oftalmisk opløsning |
Timolol (as timolol maleate) 2.5 mg/mL eye drops |
Timolol maleate 0.5% |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
timololmaleat 0,5 % oftalmisk opløsning |
Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
Timolol maleate+bendroflumethiazide |
Product containing bendroflumethiazide and timolol (medicinal product) |
Tinnitus symptom NOS |
Tinnitus |
Tinnitussymptom, ikke nærmere specificeret |
Tinnitus |
tiotropium 18 µg inhalationspulver i kapsel |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Tiotropium 18microgram inhalation powder capsule with device |
Tiotropium (as tiotropium bromide) 18 microgram/actuation powder for inhalation |
Tis (0): Carcinoma in situ begrænset til mucosa i tuba uterina |
American Joint Committee on Cancer cTis (qualifier value) |
Tis (0): Carcinoma in situ i vagina |
American Joint Committee on Cancer cTis (qualifier value) |
Tis-stadium |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Carcinoma in situ i blæren ("flad tumor") |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: carcinoma in situ i endometrium/cervix uteri |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Carcinoma in situ |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: carcinoma in situ kun epitelialt, uden indvækst |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: Carcinoma in situ i testis |
American Joint Committee on Cancer cTis (qualifier value) |
Tis: tumor med indvækst i lamina propria mucosae (gastrointestinal tumor) |
American Joint Committee on Cancer cTis(LAMN) (qualifier value) |
Tis: tumor med indvækst i lamina muscularis mucosae (colon/rectum) |
American Joint Committee on Cancer cTis (qualifier value) |
Tissue culture for chromosome analysis, more complex procedure with special extra counts |
Chromosome analysis |
Tissue cytology NOS |
Cytologic test (procedure) |
Tissue cytology NOS |
Cytologic test (procedure) |
Tissue disruption operation NOS |
Tissue disruption operation |
Tissue disruption operation NOS |
Tissue disruption operation |
Tissue injection for local action |
Administration using positive pressure and a needle or other equipment to drive a substance into the body. |
Tissue injection for local action NOS |
Administration using positive pressure and a needle or other equipment to drive a substance into the body. |
Tissue injection for local action NOS |
Administration using positive pressure and a needle or other equipment to drive a substance into the body. |
Tissue kallikrein |
Kininogen (substance) |
Tissue processing technique, complex, embed, cut and stain, per autopsy |
Tissue processing technique |
Tissue processing technique, complex, embed, cut and stain, per surgical specimen |
Tissue processing technique |